Nanoviricides (NNVC) Assets (2011 - 2026)
Nanoviricides (NNVC) posted Assets of $10.2 million for Q1 2026, down 16.7% sequentially from $12.3 million in Q4 2025, and up 1.86% YoY from $10.0 million in Q1 2025.
Nanoviricides (NNVC) Assets (2011 - 2026) Analysis & Trends
Nanoviricides has reported Assets for 16 years, with the latest figure at $10.2 million in Q1 2026.
- Quarterly Assets rose 1.86% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (up 1.86% YoY) and the FY2025 annual result came in at $8.8 million, down 31.18% from the prior year.
- Assets fell to $10.2 million in Q1 2026 per NNVC's latest filing, from $12.3 million in the prior quarter.
- Over five years, Assets peaked at $25.1 million in Q1 2022 and troughed at $8.4 million in Q3 2025.
- A 5-year average of $14.9 million and a median of $12.8 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 38.28% in 2024, then climbed 6.02% in 2025.
- Over 5 years, Assets stood at $20.3 million in 2022, then slumped by 34.09% to $13.4 million in 2023, then declined by 13.67% to $11.6 million in 2024, then grew by 6.02% to $12.3 million in 2025, then decreased by 16.7% to $10.2 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $10.2 million, $12.3 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - | 10.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.22 Mn |
| Dec 31, 2025 | 12.27 Mn |
| Sep 30, 2025 | 8.36 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 10.03 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 11.74 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Mar 31, 2024 | 11.46 Mn |
| Dec 31, 2023 | 13.40 Mn |
| Sep 30, 2023 | 15.42 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 18.58 Mn |
| Dec 31, 2022 | 20.33 Mn |
| Sep 30, 2022 | 22.08 Mn |
| Jun 30, 2022 | 23.49 Mn |
| Mar 31, 2022 | 25.14 Mn |
| Dec 31, 2021 | 26.81 Mn |
| Sep 30, 2021 | 29.18 Mn |
| Jun 30, 2021 | 30.26 Mn |